Press release
Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion
Self Administered Parenteral Market
The self-administered parenteral market has experienced strong growth in recent years. It will rise from $24.57 billion in 2024 to $26.04 billion in 2025, at a CAGR of 6.0%. This growth is driven by the rise in chronic diseases, the aging population, government initiatives, patient education and support programs, and the increasing incidences of bone disorders.
The self-administered parenteral market is expected to grow steadily, reaching $31.18 billion by 2029, at a CAGR of 4.6%. This growth is attributed to an increasing preference for home healthcare, the rise of telemedicine and remote monitoring, patient education, and the growing personalized medicine sector. Trends include the integration of digital health solutions, customized drug delivery systems, emerging targeted therapies, and advancements in biologics.
What Key Elements Are Boosting Growth in the Self-Administered Parenteral Market?
The rising prevalence of chronic diseases is expected to propel the growth of the self-administered parenteral market. Chronic diseases are long-term medical conditions that develop gradually and require ongoing treatment and management. Self-administered parenteral therapies enable patients to manage their treatment independently, improving medication adherence compared to oral drugs. For instance, in January 2023, the National Institutes of Health, a U.S. government agency, projected that among individuals aged 50 and older, the number of people with at least one chronic illness would surge by 99.5%, increasing from 71.52 million in 2020 to 142.66 million by 2050. Thus, the increasing burden of chronic diseases is driving the growth of the self-administered parenteral market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp
Who Are the Major Industry Players Fueling Self-Administered Parenteral Market Expansion?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG
Which Key Developments Are Influencing the Self-Administered Parenteral Market?
Companies in the self-administered parenteral market are developing innovative products like the UDENYCA autoinjector to improve patient accessibility and treatment options. For example, in May 2023, Coherus BioSciences Inc., a US-based biotech firm, launched the UDENYCA autoinjector in the US. This self-administered, single-dose, prefilled autoinjector offers patients a convenient option for pegfilgrastim delivery, featuring an intuitive push-on-skin activation mechanism for fast and reliable administration.
How Is the Segmentation of the Self-Administered Parenteral Market Defined?
The self-administered parenteral market covered in this report is segmented -
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report
What Is the Leading Region in the Self-Administered Parenteral Market?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Self-Administered Parenteral Global Market Report?
- Market Size Analysis: Analyze the Self-Administered Parenteral Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Self-Administered Parenteral Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Self-Administered Parenteral Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Self-Administered Parenteral Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion here
News-ID: 3854108 • Views: …
More Releases from The Business Research Company
Global Factors Influencing the Rapid Evolution of the Robotic Flight Simulator S …
The robotic flight simulator surgery market is on the verge of significant expansion as advanced technologies continue to reshape surgical training and planning. Driven by increasing adoption of virtual reality and innovative simulation tools, this sector is set to experience considerable growth over the coming years. The following analysis explores the market's valuation, key contributors, evolving trends, and the segmentation landscape.
Projected Market Size and Growth Trajectory of the Robotic Flight…
Leading Companies Consolidating Their Presence in the Responsible Artificial Int …
As artificial intelligence (AI) technologies continue to evolve and integrate deeply into business operations, the need for transparent and accountable AI practices has never been more critical. The responsible artificial intelligence (AI) reporting packs market is emerging as a vital sector dedicated to ensuring that AI systems are monitored, governed, and reported with rigor. Let's explore the expected growth, key players, industry trends, and market segments shaping this important field.
Projected…
Future Perspective: Key Trends Shaping the Regenerative Grid Simulator Market Up …
The regenerative grid simulator market is on track for significant expansion as technological advancements and increasing energy demands drive innovation. With rising focus on smart grids and electric vehicle infrastructure, this market is poised to transform energy testing and validation processes in the coming years. Here's an in-depth look at the market's size, key players, emerging trends, and major segments shaping its future.
Forecast and Market Size Growth in the Regenerative…
Analysis of Key Market Segments Driving the Quic-Enabled Content Delivery Networ …
The quic-enabled content delivery network edge industry is on track for remarkable expansion over the coming years. Driven by evolving digital needs and technological advancements, this market is set to transform how content is delivered and experienced globally. Let's explore its market size, key players, prevailing trends, and segment-specific forecasts to understand the future trajectory of this dynamic sector.
Projected Market Growth and Size of the Quic-Enable Content Delivery Network Edge…
More Releases for Administered
Leading Element Driving Change in the Self-Administered Parenteral Market in 202 …
"What combination of drivers is leading to accelerated growth in the self-administered parenteral market?
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the self-administered parenteral market. Chronic diseases are enduring health conditions that typically develop gradually and frequently necessitate continuous care and treatment. Self-administered parenteral products play a pivotal role in managing chronic conditions, allowing individuals to control their treatments, which can result in increased adherence…
Self-Administered Drugs Market Global Rising Demand & Huge Scope Till 2032
The global self-administered drugs market was valued at approximately USD 95.53 billion in 2023 and is projected to reach USD 204.08 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2032.
Self-Administered Drugs Market Overview
The self-administered drugs market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases such as diabetes, asthma, and osteoporosis. Patients are seeking convenient and effective…
Self-administered Drugs Market 2023 Trends with Analysis on Key Players
Drugs that are administered by patients themselves are known as self-administered drugs. These drugs can be taken through implantable and non-implantable infusion pumps that come in contact with the skin surface. OTC, Oral and Topical preparations are also considered self-administered drugs. Active lifestyles have prompted patients to seek drugs that would not only save time, but would enable them to avoid hospitals altogether (except in emergency cases).
Self-administered Drugs Market research…
Self-Administered Medication Market to Register Substantial Expansion by 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Request for a sample of this research report @ https://www.xploremr.com/connectus/sample/1929
Scope
The…
Self-Administered Medication Market Progresses for Huge Profits During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1929
Scope
The scope of…
Self-Administered Medication Market to Register Unwavering Growth During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
Report overview @ https://www.xploremr.com/report/1929/self-administered-medication-market
This Fact.MR report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Scope
The scope of Fact.MR’s report is to analyze…
